Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy

Akihiro Suzuki,Lianchun Xiao,Yuki Hayashi,Mariela A. Blum,James Welsh,Steven Hsesheng Lin,Jeffrey H. Lee,Manoop S. Bhutani,Brian Weston,Dipen M. Maru,David C Rice,Stephen G. Swisher,Wayne L. Hofstetter,Jeremy J. Erasmus,Jaffer A. Ajani

Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy

2012

Akihiro Suzuki
Lianchun Xiao
Yuki Hayashi
Mariela A. Blum
James Welsh
Steven Hsesheng Lin
Jeffrey H. Lee
Manoop S. Bhutani
Brian Weston
Dipen M. Maru
David C Rice
Stephen G. Swisher
Wayne L. Hofstetter
Jeremy J. Erasmus
Jaffer A. Ajani

Introduction: Level-1 evidence for definitive chemoradiotherapy (bimodality therapy or BM therapy) has been established for patients with esophageal and gastroesophageal junction ca

Keywords:

Pathology
Carcinoma
Positron emission tomography
Gastroesophageal Junction
Nomogram
Chemoradiotherapy
Esophageal cancer
Standardized uptake value
Medicine
in patient
definitive chemoradiotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations